3-ketodihydrosphingosine reductase

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Chan, Anthony K N: 1 article (01/2022)
2.	Chang, Wen-Han: 1 article (01/2022)
3.	Chen, Chun-Wei: 1 article (01/2022)
4.	Li, Mingli: 1 article (01/2022)
5.	Lin, Ren-Jang: 1 article (01/2022)
6.	Liu, Qiao: 1 article (01/2022)
7.	Lu, Wei: 1 article (01/2022)
8.	Mattson, Nicole: 1 article (01/2022)
9.	Miyashita, Kazuya: 1 article (01/2022)
10.	Pokharel, Sheela Pangeni: 1 article (01/2022)

1.	Thrombocytopenia (Thrombopenia) 08/01/2021 - "Progressive symmetrical erythrokeratoderma manifesting as harlequin-like ichthyosis with severe thrombocytopenia secondary to a homozygous 3-ketodihydrosphingosine reductase mutation."
2.	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 04/17/2007 - "A missense mutation in the 3-ketodihydrosphingosine reductase FVT1 as candidate causal mutation for bovine spinal muscular atrophy."
3.	Leukemia 01/01/2022 - "3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia." 01/01/2022 - "Using a sphingolipid network focused CRISPR/Cas9 library screen, we identified an endoplasmic reticulum (ER) enzyme, 3-Ketodihydrosphingosine reductase (KDSR), to be essential for leukemia cell maintenance. "
4.	Ichthyosis (Xeroderma) 08/01/2021 - "Progressive symmetrical erythrokeratoderma manifesting as harlequin-like ichthyosis with severe thrombocytopenia secondary to a homozygous 3-ketodihydrosphingosine reductase mutation."